Onaiza Cadoret-Manier's Net Worth
$3.35 Million
Who is Onaiza Cadoret-Manier?
Onaiza Cadoret-Manier has an estimated net worth of $3.35 Million. This is based on reported shares across multiple companies, which include IONIS PHARMACEUTICALS INC, ARDELYX, INC., and Ventyx Biosciences, Inc..
SEC CIK
Onaiza Cadoret-Manier's CIK is 0001799355
Past Insider Trading and Trends
2023 was Onaiza Cadoret-Manier's most active year for acquiring shares with 11 total transactions. Onaiza Cadoret-Manier's most active month to acquire stocks was the month of December. 2023 was Onaiza Cadoret-Manier's most active year for disposing of shares, totalling 5 transactions. Onaiza Cadoret-Manier's most active month to dispose stocks was the month of March. 2021 saw Onaiza Cadoret-Manier paying a total of $36,479.76 for 118,096 shares, this is the most they've acquired in one year. In 2023 Onaiza Cadoret-Manier cashed out on 23,645 shares for a total of $301,469.92, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
IONIS PHARMACEUTICALS INC (IONS) Snapshot price: $49
EVP, Chf GL Pdt Str & Oper Ofc
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +5.96% | 2.02K |
$49.60 | -$105,404.25 | 35.83K |
Feb 1 - Feb 2
| |||
Form 4
| +39.07% | 9.5K |
$50.42 | -$280,520.19 | 33.81K |
Jan 16 - Jan 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
| +14.53% | 3.08K |
$36.50 | -$94,249.71 | 24.31K |
Apr 17 - Apr 18
| |||
Form 4
| +14.51% | 2.69K |
$40.66 | -$58,996.93 | 21.23K |
Feb 3 - Feb 6
| |||
Form 4
| +53.35% | 6.45K |
$39.55 | -$148,223.28 | 18.54K |
Jan 17 - Jan 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
| +44.23% | 3.71K |
$41.01 | -$80,379.60 | 12.09K |
Apr 18
| |||
Form 4
| +81.04% | 3.75K |
$30.12 | -$69,426.60 | 8.38K |
Jan 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
| +10.26% | 431 |
$33.80 | $14,566.08 | 4.63K |
Aug 31
| |||
Form 4
| +753.46% | 3.71K |
$41.03 | -$80,418.80 | 4.2K |
Apr 15
| |||
Form 4
|
∞
| 492 |
$44.54 | $21,913.68 | 492 |
Feb 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Apr 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ARDELYX, INC. (ARDX) Snapshot price: $9.05
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
| +13.10% | 12.76K |
—
|
—
| 110.15K |
Jun 15
| |||
Form 4
| +1,482.37% | 91.24K |
—
|
—
| 97.39K |
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
∞
| 6.16K |
—
|
—
| 6.16K |
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ventyx Biosciences, Inc. (VTYX) Snapshot price: $2.2
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jan 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||